It was announced Saturday that the NBA has suspended New York Knicks’ center Joakim Noah for 20-games for violating the league’s anti-drug policy.
According to a league source, Noah tested positive for an over-the-counter supplement–selective androgen receptor modulator LGD-4033– that is prohibited under the outgoing Collective Bargaining Agreement.
Noah who had arthroscopic surgery on his left knee Feb. 27 has not played since Feb. 4. The suspension will not start until he is”eligible and physically able to play.” Noah is expected to serve 10 games of the suspension to finish out the 2016-17 regular season and 10 games to start the 2017-18 season.
The National Basketball Players Association’s investigation concluded that Noah hadn’t “knowingly or willingly” violated the policy and cooperated fully with the league’s probe, league sources said.
The Knicks signed Noah to a four-year $72 million contract over the summer; however his performance and not lived up to their expectations. Noah is averaging 5.0 points and 8.8 rebounds in 46 games this season.